Q1 FY27 results analysis · August 14, 2026

Relaxo Footwears Ltd Q1 FY27 Results Analysis: PAT Jumps 12.4%, Revenue Misses Goal

+12.3%PAT year on year, Rs. 54.94 Cr
Cofacto ResearchPublished August 14, 20262 min readPositive read
Quick summary

Relaxo Footwears Ltd's Q1 FY27 numbers came in strong, with revenue of Rs. 705.05 Cr (+7.73% YoY) and PAT growth of +12.35% YoY. Here's a quick read of what worked, what to watch, and what management said.

Quick Details
Results dateAugust 13, 2026
QuarterQ1 FY 2026-2027
Revenue (Q1)Rs. 705.05 Cr (+7.73% YoY)
PAT (Q1)Rs. 54.94 Cr (+12.35% YoY)
EBITDA margin15.35% (+15 bps YoY)
EPS (Q1)Rs. 2.21 (+12.76% YoY)
Market capRs. 10,441.73 Cr
CMPRs. 419.45

Quarter Snapshot

Relaxo delivered 7.7% revenue growth and 12.4% PAT growth despite severe polymer cost pressure, aided by pricing power and a temporary inventory buffer that boosted margins. The GST cut and renewable energy SPV are structural tailwinds, but margin reversal from inventory normalization and elevated employee costs are near-term risks. Management's FY27 targets are on track, albeit with revenue slightly below the ~10% goal.

Key Investment Insights

Key Positives

  • Revenue grew 7.73% YoY to Rs.705.05 Cr despite severe raw material headwinds.
  • EBITDA margin expanded 15 bps YoY to 15.35%, defying expectations of compression.
  • PAT grew 12.35% YoY to Rs.54.94 Cr.
  • Price hikes of 15-18% were sustained without volume collapse, demonstrating pricing power.
  • GST rate reduction (12% to 5%) improved competitive positioning versus unorganised sector.
  • Renewable energy SPV incorporated to lower power costs for Haryana plants.
  • Management strengthened with 10 new senior appointments across key functions.

Risk Factors

  • Direct material consumption surged to 44.18% of revenue (+6.3pp YoY) due to polymer price spike from West Asia tensions.
  • Employee benefits expense rose to 17.52% of revenue (+1.4pp YoY) due to permanent wage hike.
  • Other expenses grew 19.26% YoY, faster than revenue, indicating cost pressure.
  • Inventory build of Rs.99.25 Cr provided temporary margin benefit; reversal in Q2/Q3 could compress reported margins.
  • Revenue growth of 7.73% is below management's ~10% FY27 target.

Ask about this

Ask Cofacto a question about this result. Answers cite filings and company data.

Companies on this page

Related

Share on X · LinkedIn · WhatsApp

Disclaimer: This results analysis is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.